Keywords: corgentech, starts, new, trial, e2f, decoy, usa

Corgentech starts new trial for E2F Decoy

Article | 24 May 2004

Print This

Corgentech of the USA has initiated a Phase I/II trial of E2F Decoy (edifoligide) for the prevention of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in